{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:43Z","timestamp":1786984843781,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.atherosclerosis.2016.07.897","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T20:52:00Z","timestamp":1468702320000},"page":"194-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms"],"prefix":"10.1016","volume":"253","author":[{"given":"Piotr","family":"Chru\u015bciel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Rembek-Wieliczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Corina","family":"Serban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Ursoniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Mosteoru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib2","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mce.2014.09.014","article-title":"Essential roles of insulin, AMPK signaling and lysyl and prolyl hydroxylases in the biosynthesis and multimerization of adiponectin","volume":"399","author":"Zhang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/10408363.2015.1023429","article-title":"Biomarkers of insulin sensitivity and insulin resistance: past, present and future","volume":"52","author":"Park","year":"2015","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2009.11.035","article-title":"Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals","volume":"208","author":"Heid","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","article-title":"Race\u2013ethnic differences in adipokine levels: the Study of Women's Health across the Nation (SWAN)","volume":"61","author":"Khan","year":"2012","journal-title":"Metabol. Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib7","first-page":"1","article-title":"The interplay between sex, ethnicity, and adipose tissue characteristics","author":"Karastergiou","year":"2015","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diabetes.51.1.37","article-title":"Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes","volume":"51","author":"Stumvoll","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib10","article-title":"Epigenetics: obesity-induced hypermethylation of adiponectin gene, nature reviews","volume":"11","author":"Greenhill","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib11","first-page":"145","article-title":"Adiponectin as a target in obesity-related inflammatory state, endocrine","volume":"15","author":"Ohashi","year":"2015","journal-title":"Metabol. Immune Disorders Drug Targets Formerly Curr. Drug Targets ImmuneEndocr. Metabol. Disord."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0003319713485807","article-title":"New obesity indices and adipokines in normotensive patients and patients with hypertension comparative pilot analysis","volume":"65","author":"St\u0119pie\u0144","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5114\/aoms.2012.29518","article-title":"Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo-and hypertensive patients\u2013pilot study","volume":"8","author":"St\u0119pie\u0144","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib14","first-page":"PR13","article-title":"Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results","volume":"17","author":"Stepien","year":"2011","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib15","doi-asserted-by":"crossref","first-page":"658913","DOI":"10.1155\/2014\/658913","article-title":"New insight into adiponectin role in obesity and obesity-related diseases","volume":"2014","author":"Nigro","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1476-5381.2011.01395.x","article-title":"Adiponectin and cardiovascular health: an update","volume":"165","author":"Hui","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","article-title":"Adiponectin action from head to toe","volume":"37","author":"Brochu-Gaudreau","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2015.03.010","article-title":"The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin","volume":"135","author":"Hossain","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5604\/20831862.1150298","article-title":"Aerobic training increases the expression of adiponectin receptor genes in the peripheral blood mononuclear cells of young men","volume":"32","author":"Lee","year":"2015","journal-title":"Biol. sport"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","article-title":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials","volume":"241","author":"Sahebkar","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib22","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.2174\/1381612811319270014","article-title":"Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance","volume":"19","author":"Banach","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib23","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib24","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1. 0","volume":"5","author":"Higgins","year":"2011","journal-title":"Cochrane Collab."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib25","series-title":"Comprehensive Meta-analysis Version 2","first-page":"104","author":"Borenstein","year":"2005"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib27","series-title":"Methods for Meta-analysis in Medical Research","author":"Sutton","year":"2000"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.06.026","article-title":"Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"230","author":"Sahebkar","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2015.04.015","article-title":"Peroxisome proliferator-activated receptor gamma enhances adiponectin secretion via up-regulating DsbA-L expression","volume":"411","author":"Jin","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib31","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/srep09902","article-title":"A\u00a0systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations","volume":"5","author":"Serban","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH14-11-0937","article-title":"Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials","volume":"114","author":"Sahebkar","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","article-title":"Adiponectin and inflammation: consensus and controversy","volume":"121","author":"Fantuzzi","year":"2008","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib34","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diacare.26.10.2713","article-title":"Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial","volume":"26","author":"Keech","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib35","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes care"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/2040622315596118","article-title":"Statin use in prediabetic patients: rationale and results to date","volume":"6","author":"Kei","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1535370213517614","article-title":"Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes","volume":"239","author":"Elfakhani","year":"2014","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib38","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.2174\/13816128113196660678","article-title":"Statins and new-onset diabetes","volume":"20","author":"Barylski","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/jpet.102.036160","article-title":"Inhibition of glucose-and calcium-induced insulin secretion from \u03b2TC3 cells by novel inhibitors of protein isoprenylation","volume":"303","author":"Amin","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","article-title":"Statin therapy and plasma coenzyme Q10 concentrations\u2014A systematic review and meta-analysis of placebo-controlled trials","volume":"99","author":"Banach","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.12.111","article-title":"Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients","volume":"12","author":"Mabuchi","year":"2005","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(01)03007-1","article-title":"Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes","volume":"507","author":"Chamberlain","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib44","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0305683101","article-title":"Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets","volume":"101","author":"Maedler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","article-title":"An overview of the extra-lipid effects of rosuvastatin","volume":"13","author":"Kostapanos","year":"2008","journal-title":"J.\u00a0Cardiovasc Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1567-5688(14)70002-9","article-title":"Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin","volume":"16","author":"Arnaboldi","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1567-5688(03)00004-7","article-title":"Comparative pharmacology of rosuvastatin","volume":"4","author":"McTaggart","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1185\/03007995.2013.874989","article-title":"Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies","volume":"30","author":"Chapman","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.nut.2015.01.010","article-title":"Adiponectin may be a biomarker of early atherosclerosis of smokers and decreased by nicotine through KATP channel in adipocytes","volume":"31","author":"Fan","year":"2015","journal-title":"Nutr. (Burbank, Los Angel. Cty. Calif.)"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.5414\/CP201735","article-title":"Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose","volume":"50","author":"Buldak","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/clc.20181","article-title":"Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level","volume":"31","author":"Chan","year":"2008","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib53","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2007.06.028","article-title":"Simvastatin (40 mg\/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome","volume":"100","author":"Devaraj","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10557-012-6412-2","article-title":"The effect of HMG-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis","volume":"26","author":"Doh","year":"2012","journal-title":"Cardiovasc. drugs Ther."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3899\/jrheum.100582","article-title":"Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis","volume":"38","author":"El-Barbary","year":"2011","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jacl.2010.04.003","article-title":"Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087","volume":"4","author":"Fichtenbaum","year":"2010","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.metabol.2006.11.007","article-title":"Effect of simvastatin and\/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk\u2014the PIOSTAT Study","volume":"56","author":"Forst","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.metabol.2005.02.011","article-title":"Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients","volume":"54","author":"Gannag\u00e9-Yared","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2265.2007.03080.x","article-title":"Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men","volume":"68","author":"Gouni-Berthold","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2013.01.045","article-title":"Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus","volume":"227","author":"Kim","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib61","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib62","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.0000166722.91714.ba","article-title":"Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes","volume":"45","author":"Koh","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib64","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2009.07.002","article-title":"Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension","volume":"146","author":"Koh","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib66","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijcard.2010.10.103","article-title":"Effects of simvastatin therapy on circulating adipocytokines in patients with hypercholesterolemia","volume":"146","author":"Koh","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijcard.2011.11.028","article-title":"Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients","volume":"166","author":"Koh","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib68","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.2337\/db13-0566","article-title":"Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia","volume":"62","author":"Koh","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2337\/dc07-2199","article-title":"Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients","volume":"31","author":"Koh","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1755-5922.12057","article-title":"The effect of simvastatin\u2013ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia","volume":"32","author":"Krysiak","year":"2014","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib71","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1161\/01.CIR.0000143085.86697.13","article-title":"Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients","volume":"110","author":"Koh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/09537100802409921","article-title":"The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients","volume":"20","author":"Nomura","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2010.08.056","article-title":"Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients","volume":"213","author":"Roberto","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib75","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2169\/internalmedicine.47.1159","article-title":"Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease","volume":"47","author":"Sawara","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib76","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","volume":"27","author":"Shetty","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib77","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.atherosclerosis.2006.08.023","article-title":"Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease","volume":"194","author":"Sugiyama","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1185\/03007990802596813","article-title":"Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes*","volume":"25","author":"van Hoek","year":"2008","journal-title":"Curr. Med. Res. Opinion"},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1472-8206.2010.00847.x","article-title":"Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease","volume":"25","author":"Yokoyama","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.07.897_bib80","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1479164109339966","article-title":"Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis","volume":"6","author":"Hu","year":"2009","journal-title":"Diabetes Vasc. Dis. Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016311984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016311984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:25:53Z","timestamp":1536571553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016311984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":80,"alternative-id":["S0021915016311984"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.07.897","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.07.897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}